CELSION CORP COMMON STOCK (CLSN) Covered Calls

CELSION CORP COMMON STOCK covered calls Celsion Corporation is an innovative oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.

You can sell covered calls on CELSION CORP COMMON STOCK to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CLSN (prices last updated Mon 4:16 PM ET):

CELSION CORP COMMON STOCK (CLSN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.28 -0.21 2.27 2.34 277K - 0.0B
Covered Calls For CELSION CORP COMMON STOCK (CLSN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 2.5 0.05 2.29 2.2% 30.9%
Dec 21 2.5 0.00 2.34 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Celsion Corp. engages in the provision of oncology drug development services. It operates through developing and commercializing chemotherapeutic oncology drugs based on proprietary heat-activated liposomal technology. Its products include ThermoDox, TheraPlas, and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.